Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression (British Journal of Pharmacology (2008) 153, (66-74) DOI: 10.1038/sj.bjp.0707482);Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression

British Journal of Pharmacology

Volumn 153, Issue 1, 2008, Pages 66-74

  Zhong, J C ^a   Yu, X Y ^a   Lin, Q X ^a   Li, X H ^a   Huang, X Z ^a   Xiao, D Z ^a   Lin, S G ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Angiotensin II; Angiotensin converting enzyme 2 (ACE2); Insulin resistance; Macrophage migration inhibitory factor; Nitric oxide

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 MORPHOLINO 8 PHENYLCHROMONE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INSULIN; LOSARTAN; MACROPHAGE MIGRATION INHIBITION FACTOR; MALONALDEHYDE; MESSENGER RNA; PROTEIN KINASE B BETA; PROTEIN P22; PROTEIN P22 PHOX; SERINE; UNCLASSIFIED DRUG;

ACE2 GENE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME REGULATION; GENE CONSTRUCT; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE MIGRATION INHIBITION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT GENE; SIGNAL DETECTION; WESTERN BLOTTING;

EID: 37849022694     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707614     Document Type: Erratum

References (27)

1. Burger-Kentischer A, Gobel H, Kleemann R, Zernecke A, Bucala R, Leng L et al. (2006). Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 184: 28-38.
2. Busche S, Gallinat S, Fleegal MA, Raizada MK, Sumners C (2001). Novel role of macrophage migration inhibitory factor in angiotensin II regulation of neuromodulation in rat brain. Endocrinology 142: 4623-4630.
3. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ et al. (2003). Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124.
4. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE et al. (2002). Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828.
5. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005). Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111: 1448-1454.
6. Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D et al. (2004). Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 89: 5043-5047.
7. Der Sarkissian S, Huentelman MJ, Stewart J, Katovich MJ, Raizada MK (2006). ACE2: A novel therapeutic target for cardiovascular diseases. Prog Biophys Mol Biol 91: 163-198.
8. Esteban V, Ruperez M, Sanchez-Lopez E, Rodriguez-Vita J, Lorenzo O, Demaegdt H et al. (2005). Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells. Circ Res 96: 965-973.
9. Fingerle-Rowson GR, Bucala R (2001). Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol Cell Biol 79: 368-375.
10. Ha T, Hua F, Grant D, Xia Y, Ma J, Gao X et al. (2006). Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice. Am J Physiol Heart Circ Physiol 291: H1910-H1918.
11. Hamming I, Cooper ME, Haagmans BL, Hooper NM, Korstanje R, Osterhaus AD et al. (2007). The emerging role of ACE2 in physiology and disease. J Pathol 212: 1-11.
12. Herder C, Kolb H, Koenig W, Haastert B, Muller-Scholze S, Rathmann W et al. (2006). Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4). Diabetes Care 29: 368-371.
13. Ingelfinger JR (2006). ACE2: A new target for prevention of diabetic nephropathy? J Am Soc Nephrol 17: 2957-2959.
14. Keidar S, Kaplan M, Gamliel-Lazarovich A (2007). ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovasc Res 73: 463-469.
15. Kim JA, Montagnani M, Koh KK, Quon MJ (2006). Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 113: 1888-1904.
16. Kong YZ, Huang XR, Ouyang X, Tan JJ, Fingerle-Rowson G, Bacher M et al. (2005). Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques. Cardiovasc Res 65: 272-282.
17. Krum H, Gilbert RE (2007). Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. J Hypertens 25: 25-35.
18. Lin SG, Yu XY, Chen YX, Huang XR, Metz C, Bucala R et al. (2000). De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 87: 1202-1208.
19. Marrero MB, Fulton D, Stepp D, Stern DM (2004). Angiotensin II-induced insulin resistance and protein tyrosine phosphatases. Arterioscler Thromb Vasc Biol 24: 2009-2013.
20. Oudit GY, Crackower MA, Backx PH, Penninger JM (2003). The role of ACE2 in cardiovascular physiology. Trends Cardiovasc Med 13: 93-101.
21. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH et al. (2007). Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 75: 29-39.
22. Schmeisser A, Marquetant R, Illmer T, Graffy C, Garlichs CD, Bockler D et al. (2005). The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis 178: 83-94.
23. Takahashi M, Nishihira J, Shimpo M, Mizue Y, Ueno S, Mano H et al. (2001). Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc Res 52: 438-445.
24. Warner FJ, Smith AI, Hooper NM, Turner AJ (2004). Angiotensin-converting enzyme-2: a molecular and cellular perspective. Cell Mol Life Sci 61: 2704-2713.
25. Zhong JC, Huang DY, Liu GF, Jin HY, Yang YM, Li YF et al. (2005). Effects of all-trans retinoic acid on orphan receptor APJ signaling in spontaneously hypertensive rats. Cardiovasc Res 65: 743-750.
26. Zhong JC, Huang DY, Yang YM, Li YF, Liu GF, Song XH et al. (2004). Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 44: 907-912.
27. Zhong JC, Yu XY, Huang Y, Yung LM, Lau CW, Lin SG (2007). Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice. Cardiovasc Res 74: 388-395.